Catharina Larsson
Overview
Explore the profile of Catharina Larsson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
198
Citations
3983
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hellgren L, Stenman A, Jatta K, Condello V, Larsson C, Zedenius J, et al.
Endocr Pathol
. 2024 Oct;
35(4):411-418.
PMID: 39363120
De-escalation of thyroid cancer treatment is crucial to prevent overtreatment of indolent disease, but it remains important to identify clinically aggressive cases. TERT promoter mutations are molecular events frequently associated...
2.
Xu Y, Gao J, Wang N, Zedenius J, Nilsson I, Lui W, et al.
J Clin Endocrinol Metab
. 2024 Aug;
110(3):693-705.
PMID: 39183149
Context: BRAFV600E and TERT promoter mutations in papillary thyroid carcinoma (PTC) have a synergistic effect on prognosis. This effect is believed to arise from MAPK activation triggered by BRAFV600E, leading...
3.
Svahn F, Solhuslokk Hose K, Stenman A, Liu Y, Calissendorff J, Tham E, et al.
Endocr Relat Cancer
. 2024 Jun;
31(9).
PMID: 38864697
Pheochromocytoma (PCC) and abdominal paraganglioma (aPGL) (together abbreviated PPGL) frequently present with an underlying genetic event in a PPGL driver gene, and additional susceptibility genes are anticipated. Here, we re-analyzed...
4.
Condello V, Roberts J, Stenman A, Larsson C, Viswanathan K, Juhlin C
Virchows Arch
. 2024 Apr;
485(1):105-114.
PMID: 38637342
Somatic and biallelic DICER1 mutations are reported in subsets of thyroid tumors, supporting the role of this gene in thyroid tumor development. As recent studies have brought attention to macrofollicular...
5.
Branstrom R, Vukojevic V, Lu M, Shabo I, Mun H, Conigrave A, et al.
Exp Cell Res
. 2023 Nov;
433(2):113858.
PMID: 37995920
The relationships between parathyroid hormone (PTH) secretion and parathyroid cell membrane potential, including the identities and roles of K channels that regulate and/or modulate membrane potential are not well defined....
6.
Hysek M, Hellgren S, Condello V, Xu Y, Larsson C, Zedenius J, et al.
J Histochem Cytochem
. 2023 Jul;
71(8):451-458.
PMID: 37486076
Telomerase reverse transcriptase () gene aberrancies correlate to adverse prognosis in follicular thyroid carcinoma (FTC). As loss of 5-hydroxymethylcytosine (5hmC) has been associated with promoter mutations in papillary thyroid carcinoma,...
7.
Hysek M, Hellgren L, Stenman A, Darai-Ramqvist E, Ljung E, Schliemann I, et al.
Diagn Cytopathol
. 2023 Mar;
51(6):331-340.
PMID: 36870048
Background: Despite the advent of comprehensive molecular testing in surgical pathology, most centers still rely on the morphological assessment of fine-needle aspiration cytology (FNAC) to triage patients with thyroid nodules...
8.
Lindfors H, Karlsen M, Karlton E, Zedenius J, Larsson C, Ihre Lundgren C, et al.
Sci Rep
. 2023 Jan;
13(1):1070.
PMID: 36658256
The clinical significance of thyroglobulin (Tg) expression in papillary thyroid cancer (PTC) has not been systematically explored in relation to the Ki-67 index, lymph node ratio (LNR), or other conventional...
9.
TOP2A Expression in Pheochromocytoma and Abdominal Paraganglioma: a Marker of Poor Clinical Outcome?
Solhuslokk Hose K, Stenman A, Svahn F, Larsson C, Juhlin C
Endocr Pathol
. 2023 Jan;
34(1):129-141.
PMID: 36656469
Pheochromocytoma and abdominal paraganglioma (PPGL) are rare neuroendocrine tumors originating from chromaffin cells. Even though only 10-15% of the tumors metastasize, all PPGLs are considered potentially malignant. Topoisomerase 2A (TOP2A)...
10.
Scicluna P, Caramuta S, Kjellin H, Xu C, Frobom R, Akhtar M, et al.
Int J Oncol
. 2022 Sep;
61(5).
PMID: 36169175
Abnormalities of the insulin‑like growth factor 2 locus with the overexpression of are frequent findings in adrenocortical carcinoma (ACC). The present study assessed the expression of RNAs and microRNAs (miRNAs/miRs)...